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Abstract
Since 2003, H5N1 influenza viruses have caused over 400 known cases of human infection with a mortality rate greater than
60%. Most of these cases resulted from direct contact with virus-contaminated poultry or poultry products. Although only
limited human-to-human transmission has been reported to date, it is feared that efficient human-to-human transmission of
H5N1 viruses has the potential to cause a pandemic of disastrous proportions. The genetic basis for H5N1 viral transmission
among humans is largely unknown. In this study, we used guinea pigs as a mammalian model to study the transmission of
six different H5N1 avian influenza viruses. We found that two viruses, A/duck/Guangxi/35/2001 (DKGX/35) and A/bar-
headed goose/Qinghai/3/2005(BHGQH/05), were transmitted from inoculated animals to naı ¨ve contact animals. Our
mutagenesis analysis revealed that the amino acid asparagine (Asn) at position 701 in the PB2 protein was a prerequisite for
DKGX/35 transmission in guinea pigs. In addition, an amino acid change in the hemagglutinin (HA) protein (Thr160Ala),
resulting in the loss of glycosylation at 158–160, was responsible for HA binding to sialylated glycans and was critical for
H5N1 virus transmission in guinea pigs. These amino acids changes in PB2 and HA could serve as important molecular
markers for assessing the pandemic potential of H5N1 field isolates.
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Introduction
The H5N1 avian influenza viruses (AIVs) have attracted
extensive attention for their deadly impact on both animals and
humans. The number of people who have been subclinically
infected with H5N1 viruses is very limited [1], and H5N1 AIVs
have a 60% fatality rate in humans (World Health Organization
[WHO]; http://www.who.int). H5N1 AIVs first surfaced in China
in 1996 [2], with chicken-lethal and avirulent strains being isolated
from geese in Guangdong province [3]. In 1997, a reassortant
H5N1 AIV that carried the HA gene from an A/goose/
Guangdong/1/96-like virus caused an outbreak of disease in
poultry in Hong Kong and crossed over into humans, resulting in
18 cases of infection with six deaths [4,5]. In 2003 and 2004,
H5N1 AIVs infected poultry and humans in numerous countries
of southeastern Asia [6]. In 2005, several genotypes of H5N1 AIV
caused outbreaks in wild migratory birds at Qinghai Lake in
western China, and one genotype spread widely to different
species across a wide geographic area that included Europe and
Africa [7]. To date, H5N1 AIVs have caused disease in more than
60 countries (Office International des Epizooties [OIE]; http://
www.oie.int), with cases of human infection being reported in 15
countries (World Health Organization [WHO]; http://www.who.
int). Despite substantial efforts to control these outbreaks, H5N1
AIVs have continued to evolve and spread, perpetuating the fear
of an influenza pandemic if these viruses acquire the ability to
transmit efficiently among humans. Understanding the genetic
determinants that control H5N1 AIV transmission in mammalian
hosts will help protect public health.
The transmissibility of influenza viruses is determined by the
virus,environmentalfactors,andhostfactors[8–11].Theviraltraits
governing transmission efficiency have not been well characterized.
TheaffinityoftheviralHAproteinforsialicacida-2,6linkedglycan
(a-2,6 glycan) is necessary for transmission of the 1918 H1N1
PLoS Pathogens | www.plospathogens.org 1 December 2009 | Volume 5 | Issue 12 | e1000709influenza virus between ferrets [9]. The viral polymerase complex is
also involved in determining viral host range, replication and
pathogenicity[12–15] andplaysa role intransmission[16,17].Cold
and dry environmental conditions favor the transmission of human
influenza virus in guinea pigs [10,11].
Host factors also affect replication and transmission of influenza
viruses. Under experimental conditions, AIVs do not replicate
efficiently in humans [18], and human viruses do not replicate
efficiently in ducks [19]. In one study, the human upper airway
tract was reported to contain cells that predominantly express a-
2,6 glycan [20], an environment that favors the replication and
transmission of human influenza viruses, which preferentially bind
to a-2,6 glycans. However, in another study, viruses with
preferential binding to a-2,3 glycans were reported to bind to
cells in the human upper respiratory tract [21]. The first human
isolates in the 1957 and 1968 pandemics preferentially bound to a-
2,6 glycans even though their HAs were derived from avian
viruses, which preferentially recognize a-2,3 glycans [22]. These
findings suggest that for viruses with HAs from AIVs to be
efficiently transmitted among humans, they need to preferentially
bind to a-2,6 glycans [23].
Ferrets and guinea pigs have been successfully used as models to
evaluate the transmissibility of AIVs and other species of influenza
viruses in mammalian hosts [8,9,11,16,17,24–30]. H5N1 AIVs
exhibit varying levels of replication and virulence in mammalian
mouse and ferret models [2,13,31]. In this study, we used guinea
pigs as a mammalian model to examine the replication and
transmission of six H5N1 AIVs that exhibit different replication
and virulence phenotypes in mice. We also explored the genetic
requirements for H5N1 AIV transmission in this mammalian host.
Results
Replication of H5N1 AIVs in guinea pigs
The six H5N1 AIVs used in this study have previously been
shown to be lethal for chickens [2,13], but to differ in their
replication and lethality in mice (Table 1). To investigate the
replication of these viruses in guinea pigs, two animals were
intranasally inoculated with 10
6EID50 of virus and euthanized
three days post-inoculation (p.i.). Nasal wash, trachea, lung, brain,
kidney, spleen and colon were collected from each animal for virus
titration in eggs. A/duck/Guangxi/22/01 (DKGX/22), which
does not replicate in mice [2,13], was detected in the lung of one
guinea pig on day 3 p.i., but not in the nasal wash or trachea of
either of the other two inoculated animals (Table 1). The other five
viruses were detected in the nasal washes, tracheas and lungs of
both animals inoculated. Virus was not detected in the brains,
kidneys, spleens, or colons of any of the animals inoculated. We
also infected two animals for each virus and observed them for two
weeks for signs of pathogenicity. After two weeks p.i., all of the
animals seroconverted except for one of the two guinea pigs
infected with the DKGX/22 virus (Table 1). None of the animals
showed disease signs during the observation period. These results
Author Summary
H5N1 influenza viruses have caused over 400 human
infections in 15 countries and continue to circulate in
poultry and wild birds. Most human infections resulted
from direct contact with virus-contaminated poultry or
poultry products. It would be disastrous if H5N1 viruses
acquired the ability to efficiently transmit among humans,
because the mortality rate may exceed 60%. However, the
genetic basis for transmission of H5N1 influenza viruses is
largely unknown. Here, we demonstrate that the amino
acid residue at 701 of PB2 is a prerequisite for transmission
of H5N1 viruses in a mammalian guinea pig model.
Interestingly, we found that the absence of glycosylation
at residues 158–160 of the HA gene is pivotal for the H5N1
virus to bind to human-like receptors and to transmit in a
mammal host. These findings are important for assessing
the pandemic potential of H5N1 field isolates.
Table 1. Replication of H5N1 avian influenza viruses in guinea pigs.
Virus (abbreviation) Replication and virulence in mice
a Replication in guinea pigs
b
Virus titers in organs(log10EID50/ml)
MLD50
(log10EID50) Mean virus titers (log10EID50/gram)
Seroconversion
(positive/total)e
Lung Spleen Kidney Brain Nasal wash
c Trachea Lung
A/duck/Guangxi/22/01 (DKGX/22) 2222. 6.5 22 0.8(1/2)
d 1/2
A/duck/Fujian/17/01 (DKFJ/17) 1.460.4 222. 6.5 2.260.3 0.660.2 2.160.5 2/2
A/duck/Shanghai/13/01 (DKSH/13) 2.761.4 2225.0 1.961.6 0.860.0 3.560.2 2/2
A/duck/Guangxi/35/01 (DKGX/35) 5.162.2 1.360.8 ++1.5 2.860.0 0.860.0 3.560.0 2/2
A/duck/Guangdong/22/02 (DKGD/22) 3.261.0 2224.8 2.260.7 1.360.0 2.160.9 2/2
A/Bar-headed goose/Qinghai/3/05
(BHGQH/3)
6.360.9 2.060.3 2.560.3 2.960.7 ,0.5 3.061.7 1.460.2 2.860.4 2/2
aData shown are summarized from previous reports [2,7]. Six-week-old BALB/c mice were infected i.n. with 10
6 EID50 of each virus in a 50-ml volume. Organs were
collected on day 3 p.i., and clarified homogenates were titrated for virus infectivity in eggs at initial dilutions of 1:10 (lung), 1:2 (other tissues), or undiluted if negative at
the lowest dilution. + and 2, virus was detected or not detected, respectively, in the undiluted samples.
bGroups of four guinea pigs were slightly anesthetized and intranasally inoculated with 10
6EID50 of test virus in a 300ml volume, 150 ml per nostril. Two animals from
each group were euthanized on day 3 p.i. and samples, including nasal wash, trachea, lung, spleen, kidney, colon and brain, were collected for virus titration in eggs.
The remaining two animals were observed for two weeks and sera were collected at the end of the observation period. Virus was not detected in the spleen, kidney,
colon and brain of any animals inoculated with the six viruses, therefore, the data from these samples are not shown in the table. 2, virus was not detected in the
undiluted sample.
cData shown are log10EID50/ml.
dVirus was only detected in one of the two animals inoculated.
eSeroconversion was confirmed by hemagglutination inhibition (HI) assay.
doi:10.1371/journal.ppat.1000709.t001
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restricted to the respiratory system.
Transmission of H5N1 AIVs in guinea pigs
Groups of three animals were inoculated with 10
6 EID50 of each
virus intranasally and three naı ¨ve animals were introduced into the
same cage 24 h p.i. Evidence of transmission was based on the
detection of virus in the nasal wash and on seroconversion at the
end of the two-week observation period. As shown in Figure 1A,
virus was not detected in the nasal washes of any inoculated or
contact guinea pigs in the DKGX/22-inoculated group. In the
DKFJ/17-, DKSH/13- and DKGD/22- inoculated groups, virus
was detected in the nasal washes of all three inoculated guinea pigs
between days 2–10 p.i., but not in any of the contact guinea pigs
(Figure 1B,C,E). In the DKGX/35- and BHGQH/3-inoculated
groups, virus was detected in the nasal washes of all three
inoculated guinea pigs between days 2–6 or days 2–10 p.i.,
respectively and was also detected in the nasal washes of all three
contact animals between days 4–12 p.i. (Figure 1D, F).
Seroconversion occurred in all inoculated groups; however, in
the DKGX/22-inoculated group, only two of the three animals
seroconverted (Table 2). In the contact animal groups, serocon-
version was only observed among animals placed with the
DKGX/35- and BHGQH/3-inoculated animals. These results
indicate that the transmissibility of H5N1 AIVs in guinea pigs
varies among viral strains, and of the six test viruses, only DKGX/
35 and BHGQH/3 transmit efficiently in this mammalian host.
PB2 amino acid 701N is required but not sufficient for
H5N1 AIV transmission in guinea pigs
Of the six viruses tested, DKGX/22 and DKGX/35 have very
similar genomes [2,13]. Using DKGX/22 and DKGX/35, we
previously determined that the amino acid at position 701 in the
PB2 protein is important for H5N1 avian influenza virus
replication in mice [13]. To determine whether this amino acid
also contributes to the replication and transmission of H5N1
viruses in guinea pigs, we tested two mutants, DKGX/35-PB2-
N701D (35/PB2-701D) and DKGX/22-PB2-D701N (22/PB2-
701N) in guinea pigs. We found that when the D701N mutation
was introduced in the PB2 protein (22/PB2-701N), the replication
of the DKGX/22 virus dramatically increased. This mutant virus
replicated in the nose, trachea, and lung of the guinea pigs at titer
levels comparable to those observed in the DKGX/35-inoculated
animals (Figure 2A). In the transmission experiment, 22/PB2-
701N was detected in the noses of the inoculated guinea pigs from
days 2–8 p.i., but no virus was detected in the contact animals
(Figure 2B). The mutant 35/PB2-701D virus also replicated in the
nose, trachea, and lung of the inoculated animals, although virus
titers were appreciably lower than those observed in animals
inoculated with wild-type DKGX/35 (Figure 2A). Transmission of
35/PB2-701D in guinea pigs was not detected (Figure 2C). These
results indicate that PB2 701N is required, but not sufficient, for
transmission of these duck H5N1 AIVs in guinea pigs, suggesting
that other genes also contribute to this function.
DKGX/35 H5N1 AIV binds to both a-2,3- and a-2,6-linked
glycans
HA receptor specificity plays an important role in the
transmission of influenza viruses [9,24,26,32]. The affinity of viral
HA protein for a-2,6-glycan is required for the transmission of
human influenza virus among ferrets [8,9]. We examined the
receptor-binding specificity of DKGX/35 by hemagglutination
assays using resialyated cRBCs. DKGX/35 could bind to cRBCs
resialylated with either a-2,3- or a-2,6-glycans, wheras the H1N1
Figure 1. Transmisson of H5N1 avian influenza viruses in guinea pigs. Groups of three guinea pigs were inoculated i.n. with 10
6EID50 of test
virus and, 24 hours after the inoculation, three contact guinea pigs were placed in each cage. Nasal washes were collected every two days from all
animals beginning 2 days p.i. for detection of virus shedding. (A) DKGX/22 virus; (B) DKGX/17 virus; (C) DKSH/13 virus; (D) DKGX/35 virus; (E) DKGD/
22 virus; and (F) BHGQH/3 virus. Each color bar represents the virus titer from an individual animal. The dashed blue lines in these panels indicate the
lower limit of detection.
doi:10.1371/journal.ppat.1000709.g001
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(Figure 3).
Chandrasekaran et al reported that the sialylated glycans in the
a-2,3 and a-2,6 linkages have different topologies, and the HAs of
H1N1 and H3N2 influenza viruses that have adapted to humans
specifically bind to the long a-2,6 glycan topology, whereas the
HA of H5N1 viruses, A/Vienam/1203/04 and A/Hong Kong/
486/97, does not [33]. We tested the binding of the HAs of the
DKGX/35 and BC/05 viruses with different glycans using a dose-
dependent direct binding assay. As shown in Figure 4A, the
human H1N1 virus BC/05 bound with high affinity to short and
long a-2,6-linked glycans (69SLN and 69S-Di-LN) and showed
minimal affinity for a-2,3-linked glycans (39SLN and 39S-Di-LN).
DKGX/35 exhibited affinity for all four test glycans, although its
affinity for the a-2-3-linked glycans was slightly higher than that
for the a-2,6-linked glycans (Figure 4C). These results indicate that
the HA of the avian H5N1 DKGX/35 virus binds to a-2,6-linked
sialosides, including long a-2,6 glycans, as well as to a-2,3-linked
sialosides.
Mutation of the human influenza virus-like amino acids
226L and 228S of the DKGX/35 HA protein affects
receptor binding specificity and decreases viral
transmission in guinea pigs
Several amino acids within the H5N1 influenza virus HA gene
are associated with receptor-binding specificity [34–39]. The
DKGX/35 virus HA protein contains eight avian influenza virus-
like amino acids (Table 3). To investigate how changing these
eight amino acids to those found in human virus HAs affect H5N1
virus receptor-binding preference, we generated a series of
mutants in the DKGX/35 virus background that contained one
or two amino acid changes at these critical positions in the HA
protein. We tested their receptor binding specificities by using
hemagglutination assays. As shown in Figure 3, the mutants with
the single amino acid changes of 137A, 186K, 196R, 226L, 227N
and 228S retained the same receptor binding preference as the
wild-type DKGX/35 virus. The same result was obtained with
mutant viruses containing the double amino acid changes of
133V/138V and 186K/196R. However, the mutant containing
the double amino acid change of 226L/228S (35/HA-226L/228S)
bound to only a-2,6 glycan resialylated cRBCs and not a-2,3
glycan resialylated cRBCs. This lack of binding affinity to a-2,3
glycans was confirmed by using dose-dependent direct binding
assays (Figure 4C). Together, these data indicate that the amino
acids 226L and 228S of the HA protein are important for the
receptor binding preference of the H5N1 influenza virus, as has
been reported elsewhere [34,37].
We then asked whether this change in receptor binding
preference affected the replication and transmission of the mutant
virus in guinea pigs. The 35/HA-226L/228S virus replicated as
well as the wild-type DKGX/35 virus in the noses of guinea pigs,
but did not replicate in their tracheas and lungs (Figure 5A). In the
transmission study, the 35/HA-226L/228S virus was only
detected in two of three contact animals (Figure 4C). These
results indicate that the double amino acid mutations of Q226L
and G228S in the HA protein abate the affinity of the DKGX/35
virus to bind a-2,3 glycans, and also slightly decrease its
transmission among guinea pigs.
Table 2. Seroconversion of the guinea pigs in our H5N1 avian
influenza virus transmission studies.
Virus Seroconversion: positive/total (HI titers)
a
Inoculated Contact
DKGX/22 1/3 (10) 0/3
DKFJ/17 3/3 (10,10,10) 0/3
DKSH/13 3/3 (40, 40,80) 0/3
DKGX/35 3/3(20,10,40) 3/3 (10, 10, 10)
DKGD/22 3/3 (80, 80, 80) 0/3
BHGQH/3 3/3 (10, 40,80) 3/3 (10, 10, 10)
35/PB2-701D 3/3 (10, 80, 80) 0/3
22/PB2-701N 3/3 (40, 160, 80) 0/3
35/HA-160T 3/3 (80, 160, 320) 0/3
35/HA-226L/228S 3/3 (40, 10, 10) 1/3 (10)
R-BHGQH/3 3/3 (40, 40, 20) 3/3 (20, 10, 10)
BHGQH/3-HA 160T 3/3 (40, 40,40) 0/3
aSera were collected from guinea pigs on day 14 p.i. and treated overnight with
Vibrio cholerae receptor-destroying enzyme. Seroconversion was confirmed by
hemagglutination inhibition (HI) assay.
doi:10.1371/journal.ppat.1000709.t002
Figure 2. Replication and transmission of DKGX/35 PB2
mutants. (A) Groups of two guinea pigs were inoculated i.n. with
10
6EID50 of test virus and then euthanized on day 3 p.i. Organs were
collected for virus titration in eggs. (B) Transmission of the 22/PB2-701N
virus in guinea pigs. (C) Transmission of the 35/PB2-701D virus in
guinea pigs. The dashed blue lines in these panels indicate the lower
limit of detection.
doi:10.1371/journal.ppat.1000709.g002
Genetic Basis for Transmission of H5N1 Viruses
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160T of the DKGX/35 virus affects its receptor binding
specificity and abolishes viral transmission in guinea pigs
As shown in Table 3, the DKGX/35 HA has two amino acids,
160A and 192I, that are conserved in most human influenza
viruses. To investigate how these two amino acids affect the
receptor-binding specificity of the H5N1 virus, we generated two
mutant viruses in the DKGX/35 background, 35/HA-160T and
35/HA-192T, and analyzed their receptor binding preferences.
35/HA-160T bounds to a-2,3 glycan resialylated cRBCs but
completely lost the ability to bind to a-2,6 glycan resialylated
cRBCs, as determined by hemagglutination assays (Figure 3). The
mutation I192T did not change the receptor binding preference of
the DKGX/35 virus (Figure 3). The loss of receptor-binding
affinity of 35/HA-160T to a-2,6 glycans was further confirmed by
dose-dependent direct binding assays (Figure 4D).
We then tested the effect of the mutation A160T on the
replication and transmission of DKGX/35 in guinea pigs. 35/HA-
160T replicated as well as the wild-type DKGX/35 virus in the
respiratory system of guinea pigs (Figure 4A), but was not detected
in any of the contact animals (Figure 4B). These results indicate
that the amino acid 160A of the HA protein is required for the
H5N1 virus to bind the human a-2,6 sialic acid cellular receptors
and for its transmission among guinea pigs.
The amino acid mutation of A to T at position 160 of the
DKGX/35 HA protein formed a new potential N-linked
glycosylation site -NST- at amino acid positions 158–160. To
investigate whether this potential N-linked glycosylation site is
indeed glycosylated, we performed Western blot analysis of the
HA polypeptides of DKGX/35 and 35/HA-160T treated with or
without PNGase F enzyme. As shown in Figure 6, the HA1
polypeptide of 35/HA-160T exhibited decreased mobility relative
to that of DKGX/35 as a result of the single amino acid mutation
of A160T, whereas when the HA1 polypeptides of these two
viruses were deglycosylated with PNGase F, they showed similar
mobility (Figure 6). These results suggest that the potential N-
linked glycosylation site at amino acid positions 158–160 in the
HA protein of the 35/HA-160T virus is glycosylated.
The amino acid A160T mutation in the HA protein of the
AIV BHGQH/3 altered its receptor-binding preference
and abolished its transmission in guinea pigs
BHGQH/3 bears the amino acid A at the position 160 in its
HA gene, as does DKGX/35 (Table 4). To test how the HA
amino acid mutation A160T affects the receptor-binding and
transmission properties of BHGQH/3, we introduced this
mutation in the BHGQH/3 background by using reverse genetics.
The rescued wild-type virus, r-BHGQH/3, bound to both a-2,3
and a-2,6 glycans (Figure 7A), whereas the mutant BHGQH/3-
A160T bound to only a-2,3 glycans, as determined by dose-
dependent direct binding assays (Figure 7B). These results were
confirmed by use of hemagglutination assays (data not shown).
We also compared the transmissibility of BHGQH/3-A160T in
guinea pigs to that of the rescued r-BHGQH/3 virus. As shown in
Figure 7C, the r-BHGQH/3 virus was detected in guinea pig
nasal washes obtained between days 2–8 p.i. The virus was also
detected in contact animals between days 4–14 p.i. BHGQH/3-
A160T, however, was found in the nasal washes of only the
inoculated animals, not the contact guinea pigs (Figure 7D). These
results indicate that the amino acid mutation A160T in the HA
protein of BHGQH/3 also abolishes the its binding affinity for a-
2,3 glycans and its transmissibility in guinea pigs.
Figure 4. Glycan binding specificity of H1N1 and H5N1 viruses.
(A) H1N1 human influenza BC/05 virus. (B) DKGX/35 virus. (C) 35/HA-
226L/228S. (D) 35/HA-160T.
doi:10.1371/journal.ppat.1000709.g004
Figure 3. Hemagglutination assays of H5N1 influenza viruses
using cRBCs with different treatments. The upper panel shows the
hemagglutination by two HA units of each virus while the lower panel
shows the HA titers of test viruses with 0.5% cRBCs treated as follows:
cBRCs, untreated; Desial cRBCs, treated with VCNA; a-2,3 cRBC, VCNA
treated and resialylated with a-2,3 glycans; a-2,6 cRBC,VCNA treated
and resialylated with a-2,6 glycans.
doi:10.1371/journal.ppat.1000709.g003
Genetic Basis for Transmission of H5N1 Viruses
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system of guinea pigs
To understand the underlying mechanism of the receptor
binding specificities and replication phenotypes in guinea pigs of
the viruses used in our experiments, we examined the receptor
specificity of the respiratory tract of guinea pigs. The alveolar
surface was covered by MAAII-binding a-2,3 glycan (Figure 8A,
red), as was the surface of tracheal cells (Figure 8B, red), although
some cells also expressed SNA-binding a-2,6 glycan (Figure 8B,
green). The nasal respiratory region contained a mixture of cells
expressing a-2,3 glycan and a-2,6 glycan (Figure 8C). In the nasal
olfactory region, the cell surfaces were mostly covered by a-2,3
glycan (Figure 8D). The lack of a-2,6 glycans on the alveolar
surface may explain the inability of the 35/HA-226L/228S virus
to replicate in the lungs of guinea pigs (Figure 4A).
Discussion
H5N1 AIVs have caused the deaths of more than half of the
humans they have infected since 1997 and clearly represent a
Table 3. Amino acids that may affect the receptor-binding specificity of the influenza virus HA gene.
Amino acid position: H3
number (H5 number) Amino acid in virus
Most human influenza viruses DKGX/35 BHGQH/3 Most avian influenza viruses
133(129) Val (V) Leu (L) Leu (L) Leu (L)
137(133) Ala (A) Ser (S) Ser (S) Ser (S)
138(134) Val (V) Ala (A) Ala (A) Ala (A)
160(156) Ala (A) Ala (A) Ala (A) Thr (T)
186(182) Lys (K) Asn (N) Asn (N) Asn (N)
192(188) Ile (I) Ile (I) Thr (T) Thr (T)
196(192) Arg (R) Gln (Q) Gln (Q) Gln (Q)
226(222) Leu (L) Gln (Q) Gln (Q) Gln (Q)
227(223) Asn (N) Ser (S) Ser (S) Ser (S)
228(224) Ser (S) Gly (G) Gly (G) Gly (G)
doi:10.1371/journal.ppat.1000709.t003
Figure 5. Replication and transmission of DKGX/35 HA
mutants. (A) Groups of two guinea pigs were inoculated i.n. with
10
6EID50 of test virus and euthanized on day 3 p.i. Organs were
collected for virus titration in eggs. (B) Transmission of 35/HA-226L/
228S in guinea pigs. (C) Transmission of 35/HA-160T in guinea pigs. The
dashed blue lines in these panels indicate the lower limit of detection.
doi:10.1371/journal.ppat.1000709.g005
Figure 6. Western blot analyses of H5N1 avian influenza HA1
protein. Lysates of H5N1 viruses treated with or without PNGase F
were incubated with chicken anti-H5N1 antiserum. Binding was
visualized with 3,30-diaminobenzidine after incubation with peroxi-
dase-conjugated secondary antibodies. The locations of marker
proteins are indicated on the left.
doi:10.1371/journal.ppat.1000709.g006
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http:// www.who.int). Most human cases of infection resulted
from direct exposure to H5N1 virus-infected poultry or poultry
products. However, human-to-human transmission, albeit limited,
has been detected [40,41]. The effects of specific amino acid
changes on the transmissibility of H5N1 highly pathogenic AIVs
remain largely unexplored. Here, we evaluated the replication and
transmission in guinea pigs of six H5N1 AIVs isolated in China
between 2001 and 2005. We found that two of these viruses,
DKGX/35 and BHGQH/03, not only replicated but also
transmitted efficiently in guinea pigs. We demonstrated that the
amino acid 701N in the PB2 protein is required for DKGX/35
transmission in guinea pigs, and that DKGX/35 and BHGQH/
03 bind to both a-2,3 and a-2,6 glycans. The amino acid mutation
A160T in the HA protein, which creates a new potential N-linked
glycosylation site, abolishes the ability of viruses to bind a-2,6
glycans and to transmit in guinea pigs. Our results demonstrate
that the PB2 and HA genes play important roles in the
transmission of H5N1 influenza viruses in a mammalian host,
and we are the first to report that the lack of glycosylation at amino
acid positions 158–160 in HA is important for H5N1 AIVs to bind
to the human receptor and to transmit in a mammalian host.
PB2, together with the viral proteins PB1 and PA, makes up the
viral RNA polymerase. PB2 is an important determinant for the
Figure 7. Receptor-binding preference and transmission of BHGQH/3 and its HA mutant. Receptor-binding preference of r-BHGQH/3 (A)
and BHGQH/3-160T (B) were performed by dose-dependent direct binding assay as described in the text. (C) and (D) Transmisson of H5N1 duck
viruses in guinea pigs. (C) r-BHGQH/3-inoculated group. (D) BHGQH/3-160T-inoculated group. The dashed blue lines in these panels indicate the
lower limit of detection.
doi:10.1371/journal.ppat.1000709.g007
Table 4. Primers used to generate mutations in the HA gene of our H5N1 influenza viruses.
Mutation Primer sequence (59-39)
Forward Reverse
DKGX/35 I192T CCTAATGATGCGGCAGAGCAGACAAAGCTCTATC GATAGAGCTTTGTCTGCTCTGCCGCATCATTAGG
DKGX/35 A160T GGCTTATCAAAAAGAACAGTACATACCCAACAATAAAGAGG CCTCTTTATTGTTGGGTATGTACTGTTCTTTTTGATAAGCC
DKGX/35 S133V&A138V CAATCATGAAGCCTCAGTAGGGGTGAGCTCAGTATGTCCATACC GGTATGGACATACTGAGCTCACCCCTACTGAGGCTTCATGATTG
DKGX/35 S137A CATCAGGGGTGAGCGCAGCATGTCCATACCTG CAGGTATGGACATGCTGCGCTCACCCCTGATG
DKGX/35 N186K GGATTCACCATCCTAAGGATGCGGCAGAGCAGAT ATCTGCTCTGCCGCATCCTTAGGATGGTGAATCC
DKGX/35 Q196R GCAGAGCAGATAAAGCTCTATCGAAACCCAACCACC GGTGGTTGGGTTTCGATAGAGCTTTATCTGCTCTGC
DKGX/35 Q226L CCAAAGTAAACGGGCTAAGTGGAAGAATGGAGTTCTTC GAAGAACTCCATTCTTCCACTTAGCCCGTTTACTTTGG
DKGX/35 S227N CCAAAGTAAACGGGCAAAATGGAAGAATGGAGTTCTTC GAAGAACTCCATTCTTCCATTTTGCCCGTTTACTTTGG
DKGX/35 G228S CCAAAGTAAACGGGCAAAGTAGTAGAATGGAGTTCTTC GAAGAACTCCATTCTACTACTTTGCCCGTTTACTTTGG
DKGX/35 Q226L&G228S CCAAAGTAAACGGGCTAAGTAGTAGAATGGAGTTCTTC GAAGAACTCCATTCTACTACTTAGCCCGTTTACTTTGG
BHGQH/3 A160T GGCTTATCAAAAAGAACAATACATACCCAACAATAAAGAG CTCTTTATTGTTGGGTATGTATTGTTCTTTTTGATAAGCC
The nucleotides that have been changed are underlined and in boldface.
doi:10.1371/journal.ppat.1000709.t004
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amino acids in PB2, 627K and 701N, have been found in H5N1
influenza viruses isolated from humans [43]. These amino acids
are known to affect the replicative efficiency of H5N1 influenza A
viruses in mice [12,13]. Indeed, the amino acid 627K has been
reported to favor the replication of H5N1 influenza virus in the
upper respiratory tracts of mice and may be important for efficient
person-to-person virus transmission [15]. Steel et al. [16] found
that the amino acid residues 701N and 627K of PB2 increased the
transmission of both human and avian influenza viruses in guinea
pigs. In our study, we found that the amino acid mutation of N to
D at position 701 of PB2 completely abolished the transmission of
DKGX/35 virus among guinea pigs. The D to N mutation at
position 701 of PB2 dramatically increased the replication of
DKGX/22 in guinea pigs, but it did not confer transmissibility.
Similarly, the mutant viruses 35/HA-160T and BHGQH/3-
HA160T were unable to transmit in guinea pigs, even though both
viruses contain either 701N or 627K in the PB2 protein. These
results indicate that 701N or 627K in the PB2 protein are
prerequisites, but not sufficient, for H5N1 virus transmission in a
mammalian host.
The receptor binding specificity of HA has been implicated in
the transmissibility of influenza viruses [9,17]. Despite the ability
to infect and cause severe disease in humans, most H5N1 viruses
do not bind the a-2,6 glycan receptor with high affinity
[34,37,39]. This low receptor-binding affinity is likely a major
factor preventing H5N1 viruses from efficiently transmitting from
person to person and causing a pandemic [44]. Although several
reports have documented mutants of H5N1 influenza viruses that
have modest affinity for a-2,6 glycans [34–39], it is unknown
whether these mutations affect the transmission of the H5N1
influenza viruses in mammals. Here, we found that two H5N1
viruses, DKGX/35 and BHGQH/3, exhibited binding affinity
for both a-2,3 and a-2,6 glycans and were able to transmit among
guinea pigs. We demonstrated that the HA amino acid 160A
plays a key role in the affinity of these two viruses for a-2,6
glycans. The single HA amino acid mutation of A160T abolished
not only the binding affinity of DKGX/35 and BHGQH/3 to a-
2,6 glycans, but also the transmission of these viruses among
guinea pigs. It should be noted that viral transmission is a
polygenic trait and that mutation of HA alone does not confer
transmissibility to a virus.
Previous studies have reported that N-linked glycans close to the
HA receptor binding domain can affect receptor-binding prefer-
ence through steric hindrance or other mechanisms [45,46]. The
potential N-linked glycosylation site at HA amino acid positions
158–160 is commonly detected in H5N1 influenza viruses, but the
majority of the clade 2.2 H5N1 isolates that were first isolated
from wild birds in western China [7] and then in Europe, Africa
and the Middle East, notably lack this potential N-linked
glycosylation site [34]. Here, we demonstrated that the lack of
this potential glycosylation site at HA amino acid positions 158–
160 is critical for the H5N1 influenza viruses to bind a-2,6 glycans
and to transmit in a mammalian host.
The HA amino acids at positions 226 and 228 play key roles in the
receptor binding preference of influenza viruses [47,48]. The HAs of
human influenza viruses bear Leu at position 226 (226L) and Ser at
position 228 (228S) and preferentially recognize a-2,6 glycans [48].
Although H5N1 influenza viruses have caused over 400 cases of
human infection, the HA residues 226L and 228S have not been
detected in any isolates, based on the available sequence information.
Some naturally occurring H5N1 influenza mutants and lab-created
H5N1 influenza viruses that contain mutations in the receptor-
binding site of the HA protein, including the HA Q226L and G228S
double mutant in the A/Vietnam/1203/2004 virus background,
exhibit increased binding affinity for a-2,6 glycans, yet retain binding
affinityfora-2,3glycans[34,37].Here,wefoundthatthemutant35/
HA-226L/228S,with the doubleHAamino acid mutation of Q226L
and G228S in the DKGX/35 background, completely lost its ability
to bind to a-2,3 glycans and only bound to a-2,6 glycans. It is likely
that the HA amino acid 160A, which does not encode a potential
glycosylation site at 158–160, also contributed to the inability of 35/
HA-226L/228S to bind a-2,3 glycans.
Although the mutant virus 35/HA-226L/228S acquired human
influenza virus-like receptor binding preference, its transmission in
guinea pigs was slightly impaired relative to that of the wild-type
DKGX/35 virus. Our receptor specificity analysis revealed that
both a-2,3 and a-2,6 glycans were present in the nasal mucosa and
the trachea mucosal surface, yet only a-2,3 glycans were detected
in the alveoli of guinea pigs. This type of receptor distribution may
favor the replication and transmission of an avian virus that can
bind both a-2,3 and a-2,6 glycans, although human influenza
viruses, which bind to only a-2,6 glycans, transmit well in guinea
pigs [16]. Therefore, although the 35/HA-226L/228S virus
cannot transmit efficiently in guinea pigs, it may be able to
transmit easily in humans, which have a different receptor
distribution than guinea pigs [20].
In summary, here, we demonstrated that the PB2 and HA
proteins are important for the transmission of H5N1 influenza
viruses in a mammalian host. We confirmed that the PB2 amino
acid 701N is important for the transmission of H5N1 influenza
virus in guinea pigs, and found, for the first time, that the T to A
mutation at position 160, which results in the lack of an
oligosaccharide side chain at 158–160 of HA, is critical for the
H5N1 influenza viruses tested to bind to human-like receptors and
to transmit among a mammalian host. The absence of a potential
N-linked glycosylation site at HA amino acid positions 158–160
may serve as an important molecular marker for assessing the
pandemic potential of H5N1 field isolates. Moreover, it is
worrisome that clade 2.2 viruses bearing PB2 and HA mutations
that permit transmission among mammalian hosts continue to
circulate in wild birds and poultry across a wide geographic area.
Clearly, there is a critical need for continued surveillance of
poultry and regularly updated control measures.
Figure 8. Receptor distribution in the respiratory system of
guinea pigs. (A) Alveoli. Red staining indicates MAAII-binding a-2,3
glycan. (B) Tracheal mucosa of guinea pig. Red staining indicates the
presence of a-2,3 glycan and green staining indicates the presence of a-
2,6 glycan. (C) Nasal mucosa (respiratory region) of guinea pig. (D)
Nasal mucosa (olfactory region) of guinea pig. Green staining indicates
the presence of a-2,6 glycan.
doi:10.1371/journal.ppat.1000709.g008
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Facility
Studies with highly pathogenic H5N1 avian influenza viruses
were conducted in a biosecurity level 3+ laboratory approved by
the Chinese Ministry of Agriculture. All animal studies were
approved by the Review Board of Harbin Veterinary Research
Institute, Chinese Academy of Agricultural Sciences.
Viruses and cells
Human embryonic kidney cells (293T) were maintained in
Dulbecco’s modified Eagle’s medium supplemented with 10%
fetal bovine serum and incubated at 37uC and 5% CO2. The six
H5N1 AIVs used in this study (Table 1) were isolated from ducks
in southern China and wild birds at Qinghai Lake in northwest
China as described previously [2,7]. The construction of two PB2
mutant viruses, 22/PB2-701N and 35/PB2-701D, was reported
previously [13]. An H1N1 virus isolated from humans in 2005, A/
Baicheng/1/05(BC/05), was kindly provided by the Jilin Disease
Control and Prevention Centers in China. The viruses were
propagated in 10-day-old specific-pathogen-free (SPF) embryo-
nated chicken eggs and were stored at 270uC.
Guinea pig studies
Hartley strain female guinea pigs weighing 300–350 g and
serologically negative for influenza virus were used in these studies.
Ketamine (20 mg/kg) and xylazine (1 mg/kg) were used to
anesthetize animals by intramuscular injection.
To investigate the replication of H5N1 AIVs, groups of four
animals were anesthetized and inoculated intranasally (i.n.) with
10
6 EID50 of test virus in a 300 ml volume (150 ml per nostril). Two
animals from each group were euthanized on day 3 post
inoculation (p.i) and nasal washes, tracheas, lungs, brains, kidneys,
spleens, and colons were collected for virus titration in eggs. The
remaining two animals were observed for two weeks for signs of
disease and death.
For the contact transmission studies, groups of three animals
were inoculated i.n. with 10
6 EID50 of test virus and housed in a
cage placed inside an isolator. Three naı ¨ve animals were
introduced into the same cage 24 h later. Nasal washes were
collected at 2 day intervals, beginning on day 2 p.i. (1 day post
contact) and titrated in eggs. To prevent inadvertent physical
transmission of virus by the investigators, the contact guinea pigs
were always handled first, and gloves, implements, and napkins on
the work surface were changed between animals. The ambient
conditions for these studies were set as 20–22uC and 30%–40%
relative humidity. The airflow in the isolator was horizontal with a
speed of 0.1 m/s.
Receptor-binding analysis using hemagglutination assays
Hemagglutination assays using resialyated chicken red blood
cells (cRBCs) were performed as described previously [49,50] with
minor modifications. cRBCs were enzymatically desialyated with
Vibrio cholerae neuraminidase (VCNA; Roche, www.roche.com),
followed by resialylation using either a2–6-(N)-sialyltransferase or
a2–3-(N)-sialyltransferase (Calbiochem, www.calbiochem.com)
and CMP-sialic acid (Sigma, www.sigmaaldrich.com).
Dose-dependent direct binding to different glycans of
H5N1 avian influenza viruses
Analysis of the receptor specificity of influenza virus was
performed by using a direct solid-phase assay [33]. Briefly, a
streptavidin-coated, high-binding capacity 96-well plate (Pierce,
www.piercenet.com) was rinsed with PBS and 50ml of a 2.4 mM
solution of biotinylated glycans in PBS was added to each well and
incubated overnight at 4uC. Two a-2,6 glycans (69SLN
Neu5Aca2-6Galb1-4GlcNAcb-SpNH-LC-LC-Biotin, 69S-Di-LN
Neu5Aca2-6[Galb1-4GlcNAcb1-3]2b-SpNH-LC-LC-Biotin) and
two a-2,3 glycans (39SLN: Neu5Aca2-3Galb1-4GlcNAcb-SpNH-
LC-LC-Biotin, 39S-Di-LN Neu5Aca2-3[Galb1-4GlcNAcb1-3]2b-
SpNH-LC-LC-Biotin) were tested upon being kindly provided by
the Consortium for Functional Glycomics (Scripps Research
Institute, Department of Molecular Biology, La Jolla, CA). The
plate was subsequently washed with cold PBS to remove any
excess glycans. Virus was inactivated by adding 0.1% (v/v) b-
propiolactone for 3 days at 4uC. Virus binding to the glycan-
coated wells was performed by adding serially diluted virus in PBS
containing 1% bovine serum albumin (BSA) to each well followed
by an overnight incubation at 4uC. After being rinsed with PBS
containing 0.05% Tween-20 to excess virus, the wells were
incubated with chicken antisera against A/goose/Guangdong/
01/1996 (H5N1) virus for 5 h at 4uC. The wells were then
extensive washed and subsequently incubated with HRP-linked
goat-anti-chicken antibody (Sigma-Aldrich, www.sigmaaldrich.
com) for 2 h at 4uC. The wells were washed again with PBS
containing 0.05% Tween-20, and incubated with O-phenylenedi-
amine in substrate solution containing 0.01% H2O2 for 10 min at
room temperature. The reaction was stopped by adding 50 mlo f
1M H2SO4 and the absorbance was determined at 492 nm.
Site-directed mutagenesis and virus generation
The HA mutants of DKGX/35 and BHGQH/3 viruses were
generated using reverse genetics as previously described [13]. A
site-directed mutagenesis kit (Invitrogen, www.invitrogen.com) was
used to create specific mutations in the HA gene by using the
primers shown in Table 4. The plasmids used for transfection were
prepared by using the QIAfilter
TM Plasmid Midi kit (QIAGEN,
www.qiagen.com). All the constructs were completely sequenced
to ensure the absence of unwanted mutations.
Deglycosylation using PNGase F
Deglycosylation was achieved by using PNGase F (New
England Biolabs, www.neb.com). Virus was concentrated by
ultrafiltration with Microcon YM-100 tubes (Millipore, www.
millipore.com) and purified by using column chromatography with
Sepharose 4FF (GE Healthcare, www.gehealthcare.com). The
virus concentrates were denatured according to manufacturer’s
instructions, and then deglycosylated by incubation at 37uC for
16 h with the PNGase F enzyme in the buffer provided by the
manufacturer and NP40 at a final concentration of 1% (provided
with the enzyme). Deglycosylated samples were analyzed by SDS-
PAGE and western blot.
Western blot analysis
Virus samples were analyzed by SDS-PAGE and Western
immunoblotting as described previously [51]. Chicken antisera
induced by the pCAGG-HA DNA vaccine [52] was used as the
primary antibody, and IRDye
TM700DX-conjugated goat anti-
chicken immunoglobulin G (IgG) (Rockland, www.rockland-inc.
com) was used as the secondary antibody.
Detection of a-2,3 glycans and a-2,6 glycans in guinea
pig respiratory tissues
Paraffin-embedded, surgically removed, normal guinea pig
upper-to-lower respiratory tract tissues were cut into 5 mm thick
sections with a microtome. The sections were mounted on 3-
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Ind., Ltd., www.matsunami-glass.co.jp), deparaffinized in xylene,
and rehydrated with alcohol. To detect sialyloligosaccharides
reactive with a-2,3 glycan- or a-2,3 glycan-specific lectins, the
sections were incubated with 250 ml of FITC-labeled Sambucus nigra
(SNA) lectin (Vector Laboratories, www.vectorlabs.com) or
biotinylated Maackia amurensis (MAA) lectin (Vector Laboratories,
www.vectorlabs.com) overnight at 4uC. After three washes with
Tris-buffered saline (TBS, pH 7.6), the sections were incubated
with Alexa Fluor 594-conjugated streptavidin, (Molecular Probes,
Inc., www.invitrogen.com) for 2 h at room temperature. They
were then counterstained with 49,6-diamino-2-phenylindole,
dihydrochloride (DAPI; Dojindo Molecular Technologies, Inc.,
www.dojindo.com). After three washes with TBS, the sections
were then mounted on cover glasses and observed with a
fluorescence microscope (ECLIPSE TE300 with a fluorescence
equipment mercury set, Nikon Co., www.nikonusa.com). Photo-
graphs were taken with a digital microscope camera (Olympus
DP70, Olympus Optical Co., Ltd., www.olympus.com).
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